SCHEDULE OF EARNINGS PER SHARE COMMON STOCK EQUIVALENTS ANTI DILUTIVE (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2025 shares	Sep. 30, 2024 shares	Sep. 30, 2025 Integer shares	Sep. 30, 2024 shares
Product Information [Line Items]
Total common stock equivalents	25,557,507	279,817	25,557,507
Number of operating reportable segments | Integer			2
Customer Concentration Risk [Member] | Accounts Receivable [Member] | One Customer [Member]
Product Information [Line Items]
Concentration Risk, Percentage			51.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Customer [Member]
Product Information [Line Items]
Concentration Risk, Percentage			29.00%
Warrants for Placement Agents [Member]
Product Information [Line Items]
Total common stock equivalents	3,855,822	44,217	3,855,822
Strategic Advisor Warrants [Member]
Product Information [Line Items]
Total common stock equivalents	9,917,844		9,917,844
Restricted Stock [Member]
Product Information [Line Items]
Total common stock equivalents	4,280,822		4,280,822
Options Held [Member]
Product Information [Line Items]
Total common stock equivalents	856,164		856,164
Warrant [Member]
Product Information [Line Items]
Total common stock equivalents	6,646,855	145,600	6,646,855
Other Shares to be Issued [Member]
Product Information [Line Items]
Total common stock equivalents		90,000